New!: The 2022 ASTRO-Myovant Sciences-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge is now open and accepting prostate cancer research proposals until July 18, 2022. The target budget for each individual project grant is up to $500,000. Interested researchers can go to http://www.pfizer.com/ISR to sign up for alerts or email the Scientific Affairs team with inquiries.
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.